liraglutide semaglutide tirzepatide Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and # liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Teaching obesity/weight management this week
Description
By activating both GLP-1 and GIP receptors, it significantly reduces appetite and prolongs digestion, helping you feel full for longer
Your waist shrinks
Huang EJ, Reichardt LF
Clinical trials have shown strong weight loss results in adults, but data on nursing individuals and the transfer of the drug into breast milk remain limited
Please be aware that a 3.25% fee applies when paying by credit card
Together, these findings suggest that Tirzepatide does more than temporarily modify protein levelsit resets the epigenetic switches that control long-term neuronal fate
